Procyrion is dedicated to improving the quality of life of millions of heart failure patients through the development of safe and innovative circulatory assist devices. Procyrion is currently engaged in the development of the Aortix heart pump, designed to be the first non-surgical, minimally...
VitalPath manufactures custom, highly complex catheter solutions for medical device companies. We specialize in meeting customers' most challenging requirements, like single or multidirectional deflection, pushability, kink resistance, and torque response. With more than 20 years of experience, we...
To deliver on our commitments to patients and healthcare providers, Sorin Group teams continue to research, develop, and deliver reliable and state-of-the-art therapeutic solutions that address unmet cardiovascular needs and improve patient outcomes.
BioStable Science and Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.
On-X Life Technologies is a leading manufacturer of artificial heart valve replacement and repair products. On-X aortic and mitral prosthetic valves are FDA approved and have been safely implanted in approximately 200,000 patients worldwide.
Thoratec is the world leader in mechanical circulatory support with the broadest product portfolio to treat the full range of clinical needs for patients suffering from advanced heart failure. The company's products include the HeartMate LVAS and Thoratec VAD, with more than 20,000 devices...
Transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve demonstrated 75% lower rates of 30-day all-cause mortality and disabling stroke compared to surgery in intermediate-risk patients.
We are a global medical device company dedicated to delivering safe, high-performing and transformative therapies that enable patients with heart failure to get back to life. Our innovative technologies are creating advances in the miniaturization of Ventricular Assist Devices (VADs) leading to...
